about
Evaluation of targeted influenza vaccination strategies via population modelingEvolution in health and medicine Sackler colloquium: a public choice framework for controlling transmissible and evolving diseasesInfluenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case studyA data-driven mathematical model of CA-MRSA transmission among age groups: evaluating the effect of control interventionsAssessing the potential of a candidate dengue vaccine with mathematical modelingDo people taking flu vaccines need them the most?Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildrenThe population impact of a large school-based influenza vaccination campaignThe shifting demographic landscape of influenzaOptimal pandemic influenza vaccine allocation strategies for the Canadian populationTrends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocolGeographic prioritization of distributing pandemic influenza vaccines.The use of mathematical models to inform influenza pandemic preparedness and response.The Institute of Medicine's Forum on Medical and Public Health Preparedness for Catastrophic Events: regional workshop series on the 2009 H1N1 influenza vaccination campaign.Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic.Estimating the incidence reporting rates of new influenza pandemics at an early stage using travel data from the source country.The contribution of social behaviour to the transmission of influenza A in a human population.Transmission characteristics of different students during a school outbreak of (H1N1) pdm09 influenza in China, 2009.Assessing the use of antiviral treatment to control influenza.Responding to vaccine safety signals during pandemic influenza: a modeling study.Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenAssessment of intensive vaccination and antiviral treatment in 2009 influenza pandemic in Korea.Modelling mitigation strategies for pandemic (H1N1) 2009.Optimizing allocation for a delayed influenza vaccination campaign.Optimal pandemic influenza vaccine allocation strategies for the canadian population.Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemicThe shifting demographic landscape of pandemic influenza.Model-based reconstruction of an epidemic using multiple datasets: understanding influenza A/H1N1 pandemic dynamics in Israel.Pandemic dynamics and the breakdown of herd immunity.Efficient Vaccine Distribution Based on a Hybrid Compartmental ModelTargeting vaccination against novel infections: risk, age and spatial structure for pandemic influenza in Great BritainThe dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza.The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.Optimizing vaccine allocation at different points in time during an epidemic.Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched VaccinesAbsence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.A high-resolution human contact network for infectious disease transmission.Assortativity and the Probability of Epidemic Extinction: A Case Study of Pandemic Influenza A (H1N1-2009)Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study.
P2860
Q21136144-72D19A49-FC6E-41C4-8C7C-AD496177EE48Q24620815-0F54D7A4-D217-4328-8F85-BA8291168E4EQ28476585-4DF60A99-16B9-405B-BFE3-8868C7C4570AQ28535329-1C51D779-9AFE-4DFF-847E-28E9EF24E16FQ28730914-39AE23BF-63D8-414D-A3E0-4A603339B970Q28742021-AB6D528B-5F93-42BE-A441-90DB8538581BQ28743079-9041159B-87E0-4D7A-996E-CADF1680646FQ28743825-D429AEBE-1248-4E74-888A-F71D58E17711Q28750491-28F2CF17-2B3E-4FA8-8144-256E2FF6B5A7Q28752312-BC3D6E43-A966-45D0-A3A3-E0D293B0EE08Q30223026-9ACE9461-1A83-499D-948A-71995F3C9A31Q30224611-B6C5F593-48C4-49CF-8229-8CDF549EACB4Q30226500-F1D489D3-3F54-411C-BECD-4C1AED99DDEFQ30226688-258E7E9B-5BE8-4603-A9F1-82DF8D9C398CQ30226721-95B7617C-A00F-496B-BF65-525048BBB91FQ30227160-E0C300A1-2735-461E-87EE-56852BBD1BCDQ30354261-D33BE798-331B-4930-A37F-9E8CC85B0CDCQ30364008-4A0E7442-1405-40EA-B41F-CBFB9FFDB758Q30365504-D523EEA9-8E2F-461C-AEC5-FD3E03098190Q30367363-0672551E-A1F4-4C55-9E84-AA2FD9C4C9F4Q30370076-0581CDF5-97EF-4428-9F11-F472329EAFFBQ30371111-966664A7-5A1F-4DF6-9139-55D388A59C36Q30372381-1214D6E3-0653-4C33-A6EA-6B155757CAE0Q30381617-8F515E31-B77F-4880-94EC-C260885682A3Q30383876-B2ABEF74-515A-4A18-A9BD-BBB095FA1172Q30384318-0DAE9E71-B7F5-4223-A38A-234D06C9431DQ30385394-3D8DA485-8ADB-49C6-A74C-D85D07EA11B6Q30386197-9FFB600B-55B1-4D3E-824D-08E3D83A3ABBQ30386260-CB8B1606-8518-4CB0-8E3E-F2AFC590A98DQ30387011-54DB452D-9B1B-49FB-891F-0849A9229A46Q30388569-CDC714EF-CC5F-46DE-8082-1CA224A3F028Q30394832-335F8533-68EB-46AA-9533-CF43DAFAD7AAQ30394874-3B13A951-A539-4A8B-8909-152352AE0970Q30395114-19802C55-497F-49B6-839F-0D52684DC016Q30396382-15480E86-2B50-469C-942A-A94CCB07ABDBQ30396482-FB273FB1-6915-416A-AE9B-8EA8C4C94D00Q30397104-E618EC0C-47EB-44A4-94F0-4DA910D6C487Q30397278-A26E0555-3900-4A9D-8B84-987450CB084BQ30398574-F7848C2C-55EA-4D3F-B6F3-A541FE844EE3Q30398712-81891FDC-D4D5-414D-97CE-A194E3C5EA6E
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Optimizing influenza vaccine distribution.
@en
Optimizing influenza vaccine distribution.
@nl
type
label
Optimizing influenza vaccine distribution.
@en
Optimizing influenza vaccine distribution.
@nl
prefLabel
Optimizing influenza vaccine distribution.
@en
Optimizing influenza vaccine distribution.
@nl
P2860
P356
P1433
P1476
Optimizing influenza vaccine distribution.
@en
P2093
Jan Medlock
P2860
P304
P356
10.1126/SCIENCE.1175570
P407
P577
2009-08-20T00:00:00Z